Estrogen replacement stimulates fatty acid oxidation and impairs post-ischemic recovery of hearts from ovariectomized female rats

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 10, 2002, Pages 1001-1007

  Grist, Mark ^a   Wambolt, Richard B ^a   Bondy, Gregory P ^a   English, Dean R ^a   Allard, Michael F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Estrogen; Fatty acid oxidation; Ischemia; Reperfusion

Indexed keywords

CORN OIL; ESTRADIOL; ESTROGEN; FATTY ACID; GLUCOSE; INSULIN; LACTIC ACID; PALMITIC ACID DERIVATIVE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ESTROGEN THERAPY; FATTY ACID OXIDATION; FEMALE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HORMONAL REGULATION; ISOLATED HEART; ISOTOPE LABELING; LABORATORY TEST; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; TREATMENT FAILURE; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECT; HEART; HEART MUSCLE; IN VITRO STUDY; METABOLISM; ORGAN SIZE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; ESTRADIOL; ESTROGENS; FATTY ACIDS; FEMALE; HEART; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; ORGAN SIZE; OVARIECTOMY; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036442988     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-131     Document Type: Article

References (46)

1. Allard, M.F., Schonekess, B.O., Henning, S.L., English, D.R., and Lopaschuk, G.D. 1994. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am. J. Physiol. 267(2 Pt 2): H742-H750.
2. Bowles, D.K., Bey, L., Hamilton, M., and Hay, M. 2002. Estrogen effect on myocardial gene expression. FASEB J. 16(4 Pt II): A-883.
3. Brown-Grant, K., Exley, D., and Naftolin, F. 1970. Peripheral plasma oestradiol and luteinizing hormone concentrations during the oestrous cycle of the rat. J. Endocrinol. 48(2): 295-296.
4. Campbell, S.E., and Febbraio, M.A. 2001. Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 281(4): E803-E808.
5. Chambless, L., Keil, U., Dobson, A., Mahonen, M., Kuulasmaa, K., Rajakangas, A.M., Lowel, H., and Tunstall-Pedoe, H. 1997. Population versus clinical view of case fatality from acute coronary heart disease: Results from the WHO MONICA Project 1985-1990. Multinational MONItoring of trends and determinants in cardiovascular disease. Circulation, 96(11): 3849-3859.
6. Cotran, R.S., Kumar, V., and Collins, T. 1999. Pathologic Basis of Disease. W.B. Saunders Co., Philadelphia, Penn.
7. Delyani, J.A., Murohara, T., Nossuli, T.O., and Lefer, A.M. 1996. Protection from myocardial reperfusion injury by acute administration of 17 β-estradiol. J. Mol. Cell. Cardiol. 28: 1001-1008.
8. Djouadi, F., Weinheimer, C.J., Saffitz, J.E., Pitchford, C., Bastin, J., Gonzalez, F.J., and Kelly, D.P. 1998. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice. J. Clin. Invest. 102(6): 1083-1091.
9. Ellis, G.S., Lanza-Jacoby, S., Gow, A., and Kendrick, Z.V. 1994. Effects of estradiol on lipoprotein lipase activity and lipid availability in exercised male rats. J. Appl. Physiol. 77(1): 209-215.
10. Fraser, H., Davidge, S.T., and Clanachan, A.S. 1999. Enhancement of post-ischemic myocardial function by chronic 17-beta-estradiol treatment: Role of alterations in glucose metabolism. J. Mol. Cell. Cardiol. 31(8): 1539-1549.
11. Greendale, G.A., Lee, N.P., and Arriola, E.R. 1999. The menopause. Lancet, 353(9152): 571-580.
12. Grohe, C., Kahlert, S., Lobbert, K., Stimpel, M., Karas, R.H., Vetter, H., and Neyses, L. 1997. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett. 416(1): 107-112.
13. Hale, S.L., Birnbaum, Y., and Kloner, R.A. 1996. β-Estradiol, but not β-estradiol, reduces myocardial necrosis in rabbits after ischemia and reperfusion. Am. Heart J. 132: 258-262.
14. Hatta, H., Atomi, Y., Shinohara, S., Yamamoto, Y., and Yamada, S. 1988. The effects of ovarian hormones on glucose and fatty acid oxidation during exercise in female ovariectomized rats. Horm. Metab. Res. 20(10): 609-611.
15. Henning, S.L., Wambolt, R.B., Schonekess, B.O., Lopaschuk, G.D., and Allard, M.F. 1996. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation, 93(8): 1549-1555.
16. Hulley, S., Grady, D., Bush, T., Furberg, C. Herrington, D., Riggs, B., and Vittinghoff, E. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) Research Group. J. Am. Med. Assoc. 280(7): 605-613.
17. Kalra, S.P., and Kalra, P.S. 1974. Effects of circulating estradiol during rat estrous cycle on LH release following electrochemical stimulation of preoptic brain or administration of synthetic LRF. Endocrinology, 94(3): 845-851.
18. Kendrick, Z.V., and Ellis, G.S. 1991. Effect of estradiol on tissue glycogen metabolism and lipid availability in exercised male rats. J. Appl. Physiol. 71(5): 1694-1699.
19. Knowlton, A.A., and Sun, L. 2001. Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. Am. J. Physiol. 280: H455-H464.
20. Kober, L., Torp-Pedersen, C., Ottesen, M., Rasmussen, S., Lessing, M., and Skagen, K. 1996. Influence of gender on short- and long-term mortality after acute myocardial infarction. TRACE study group. Am. J. Cardiol. 77(12): 1052-1056.
21. Kolodgie, F.D., Farb, A., Litovsky, S.H., Narula, J., Jeffers, L.A., Lee, S.J., and Virmani, R. 1997. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J. Mol. Cell. Cardiol. 29(9): 2403-2414.
22. Kostis, J.B., Wilson, A.C., O'Dowd, K., Gregory, P., Chelton, S., Cosgrove, N.M., Chirala, A., and Cui, T. 1994. Sex differences in the management and long-term outcome of acute myocardial infarction. A statewide study. MIDAS Study Group. Myocardial infarction data acquisition system. Circulation, 90(4): 1715-1730.
23. Kudenchuk, P.J., Maynard, C., Martin, J.S., Wirkus, M., and Weaver, W.D. 1996. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry). Am. J. Cardiol. 78(1): 9-14.
24. Lopaschuk, G.D., Belke, D.D., Gamble, J., Itoi, T., and Schonekess, B.O. 1994. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim. Biophys. Acta, 1213(3): 263-276.
25. Malacrida, R., Genoni, M., Maggioni, A.P., Spataro, V., Parish, S., Palmer, A., Collins, R., and Moccetti, T. 1998. A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N. Engl. J. Med. 338(1): 8-14.
26. McHugh, N.A., Cook, S.M., Schairer, J.L., Bidgoli, M.M., and Merrill, G.F. 1995. Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: Effects of estrogen. Am. J. Physiol. 268(6 Pt 2): H2569-2573.
27. McPherson, R. 2000. Is hormone replacement therapy cardio-protective? Decision-making after the heart and estrogen/progestin replacement study. Can. J. Cardiol. 16(Suppl. A): 14A-19A.
28. Mora, O.A., Cabrera, M.M., and Sanchez-Criado, J.E. 1994. Hormonal pattern of the pheromonal restoration of cyclic activity in aging irregularly cycling and persistent-estrus female rats. Biol. Reprod. 51(5): 920-925.
29. Mosca, L., Manson, J.E., Sutherland, S.E., Langer, R.D., Manolio, T., and Barrett-Connor, E. 1997. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation, 96(7): 2468-2482.
30. Neely, J.R., Rovetto, M.J., and Oram, J.F. 1972. Myocardial utilization of carbohydrate and lipids. Prog. Cardiovasc. Dis. 15(3): 289-329.
31. Node, K., Masafumi, K., Hiroaki, K., Minamino, T., Funaya, H., and Hori, M. 1997. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17 β-estradiol: Role of nitric oxide an calcium-activated potassium channels. Circulation, 96: 1953-1963.
32. Persky, A.M., Green, P.S., Stubley, L., Howell, C.O., Zaulyanov, L., Brazeau, G.A., Simpkins, J.W. 2000. Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc. Soc. Exp. Biol. Med. 223: 59-66.
33. Ramirez, I. 1980. Relation between estrogen-induced hyperlipemia and food intake and body weight in rats. Physiol. Behav. 25(4): 511-518.
34. Randle, P.J. 1986. Fuel selection in animals. Biochem. Soc. Trans. 14(5): 799-806.
35. Rossouw, J.E., and the Writing Group for the Women's Health Initiative. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principle results from the Women's Health Initiative Randomized Controlled Trial. JAMA, 288(3): 321-333.
36. Sack, M.N., Rader, D.J., and Cannon, R.O., 3rd. 1994. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet, 343(8892): 269-270.
37. Saddik, M., and Lopaschuk, G.D. 1991. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J. Biol. Chem. 266(13): 8162-8170.
38. Smith, P.J., Ornatsky, O., Stewart, D.J., Picard, P., Dawood, F., Wen, W.H., Liu, P.P., Webb, D.J., and Monge, J.C. 2000. Effects of estrogen replacement on infarct size, cardiac remodeling, and the endothelin system after myocardial infarction in ovariectomized rats. Circulation, 102(24): 2983-2989.
39. Squadrito, F., Altavilla, D., Squadrito, G., Campo, G.M., Arlotta, M., Arcoraci, V., Minutoli, L., Saitta, A., and Caputi, A.P. 1997. The involvement of tumour necrosis factor-α in the protective effects of 17 β oestradiol in splanchnic ischaemia-reperfusion injury. Br. J. Pharmacol. 121: 1782-1788.
40. Stanley, W.C., Lopaschuk, G.D., Hall, J.L., and McCormack, J.G. 1997. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc. Res. 33(2): 243-257.
41. Steffansen, C.H., Roepstorff, C., Madsen, M., and Kiens, B. 2002. Myocellular triacylglycerol breakdown in females but not in males during exercise. Am. J. Physiol. 282(3): E634-E342.
42. Tarnopolsky, M.A. 2000. Gender differences in substrate metabolism during endurance exercise. Can. J. Appl. Physiol. 25(4): 312-327.
43. Tiidus, P.M. 2000. Estrogen and gender effects on muscle damage, inflammation, and oxidative stress. Can. J. Appl. Physiol. 25(4): 274-287.
44. Vaccarino, V., Krumholz, H.M., Berkman, L.F., and Horwitz, R.I. 1995. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation, 91(6): 1861-1871.
45. Vaccarino, V., Parsons, L., Every, N.R., Barron, H.V., and Krumholz, H.M. 1999. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N. Engl. J. Med. 341(4): 217-225.
46. Vaccarino, V., Abramson, J.L., Veledar, E., and Weintraub, W.S. 2002. Sex differences in hospital mortality after coronary artery bypass surgery: Evidence for a higher mortality in younger women. Circulation, 105(10): 1176-1181.